Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study

Documenti analoghi

• Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross‐sectional study
  di: Kanishk Kaushik, et al.
  Pubblicazione: (2024)
• Usefulness of combined telemedicine for self‐injection of calcitonin gene‐related peptide pathway targeting monoclonal antibodies
  di: Takao Takeshima, et al.
  Pubblicazione: (2024)
• Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti‐calcitonin gene‐related peptide therapies: The PREVENAC study
  di: Ana Beatriz Gago‐Veiga, et al.
  Pubblicazione: (2024)
• Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison
  di: María-del-Pilar Briceño-Casado
  Pubblicazione: (2020)
• Reduction rate of anti‐acetylcholine receptor antibody titer levels is an early prognostic indicator for myasthenia gravis
  di: Yasuhiro Hamada, et al.
  Pubblicazione: (2024)